test

Derek Gould

@Logos Global Management Lp

Latest period2024 - Q3ReportedManaged Assets$926.849MTotal holdings55
Assets growth rate-62.55%Assets growth rate (2-Q avg)18.89%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Logos Global Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 926.849M in assets, with a quarterly growth rate of -62.55% and a 2-quarter average growth rate of 18.89%. The portfolio is managed by Derek Gould, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IONSIonis Pharmaceuticals Inc
Recent Activity
Increased 25%
3.25%
$30.045M
750,000 shares@ $40.06 avg price
ERASErasca Inc
Recent Activity
Decreased -7.62%
3.22%
$29.757M
10.9M shares@ $2.73 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
Decreased -79.16%
3.12%
$28.84M↑ Call
1M shares@ $28.84 avg price
MRUSMerus N V
Recent Activity
Decreased -66.17%
3.1%
$28.727M
575,000 shares@ $49.96 avg price
GLPGGalapagos Nv
Recent Activity
New Position
2.49%
$23.032M
800,000 shares@ $28.79 avg price
AKROAkero Therapeutics Inc
Recent Activity
Decreased -50%
2.48%
$22.952M
800,000 shares@ $28.69 avg price
DSGNDesign Therapeutics Inc
Recent Activity
Decreased -58.09%
2.45%
$22.691M
4.218M shares@ $5.38 avg price
VERAVera Therapeutics Inc
Recent Activity
Decreased -73.68%
2.39%
$22.1M
500,000 shares@ $44.2 avg price
COGTCogent Biosciences Inc
Recent Activity
New Position
2.34%
$21.6M
2M shares@ $10.8 avg price
CYTKCytokinetics Inc
Recent Activity
New Position
2.28%
$21.12M
400,000 shares@ $52.8 avg price